Galliford Try PLC
30 March 2006
Galliford Try plc
Resolutions passed at an EGM on 30 March 2006
Two copies of the resolutions put to shareholders and passed by the required
majority at an EGM of the Company today have been submitted to the UK Listing
Authority and will shortly be available for inspection at its Document Viewing
Facility, situated at:
Financial Services Authority
25 The North Colonnade
Canary Wharf
London E14 5HS
(Tel: 020 7006 1000):
Set out below are the voting proxies in respect of the resolutions received by
the Company at the close of books on Tuesday 28 March 2006. The number of
ordinary shares of 5p in issue at that date was 226,837,828.
Votes to be cast Total Proxy Vote
at the Chairman's
Resolution Votes For discretion Votes Against Abstentions
Number
1 127,734,335 371,464 41,966 262,619 128,410,384
2 127,548,345 531,808 52,747 277,484 128,410,384
3 127,113,779 683,698 172,777 440,130 128,410,384
Enquiries:
Paul Money, Assistant Company Secretary
01895 855252
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.